Lundbeck Canada is a subsidiary of H. Lundbeck A/S, an international research-based pharmaceutical company focused on brain diseases. Based in Montreal, Lundbeck Canada has been active in the Canadian pharmaceutical industry for over two decades, marketing products for the treatment of brain diseases such as depression, anxiety, Alzheimer’s disease, schizophrenia and bipolar disorders.
Through research, development, education, and partnerships with other companies and patient organizations, Lundbeck employees aim to improve the quality of life for people living with brain diseases.
Lundbeck Canada is proud to be recognized as one of Montreal’s Top Employers, 2022.
The Lundbeck Foundation has brought discoveries to life for more than 60 years.
A specialized biopharmaceutical company focused exclusively on brain diseases.
Take your next career step with Lundbeck.